| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |